4 assets in Adamantinous Craniopharyngioma

Therapeutic assets addressing Adamantinous Craniopharyngioma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Fog-001 Adamantinous Craniopharyngioma	Parabilis Medicines, Inc.	P1/2	CCC (48)
Nivolumab Adamantinous Craniopharyngioma	Parabilis Medicines, Inc.	P1/2	CCC (48)
Tipiracil Adamantinous Craniopharyngioma	Parabilis Medicines, Inc.	P1/2	CCC (48)
Trifluridine Adamantinous Craniopharyngioma	Parabilis Medicines, Inc.	P1/2	CCC (48)